Charanjeet Arora

Charanjeet Arora

Active Director Director DIN 05250129
DIN 05250129 First appointment Apr 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Apr 2012
Shareholding value •••• Premium profile

About Charanjeet Arora

Data last updated:

Charanjeet Arora is a Director at Fujin Kami Pharmaceutico Private Limited (since 2019), Director at A-3 Overseas Private Limited (since 2023) and Designated Partner at Uniblessed Pharma Llp (since 2017). The companies operate in Pharma, Food and Beverages and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹4.78 Cr; the largest is Fujin Kami Pharmaceutico Private Limited at ₹3.99 Cr (FY 2024). Earlier, Charanjeet Arora was a Director at Mutual Pharma Private Limited (2012–2013) and Designated Partner at Fujin Kami Pharmaceutico Llp (from 2017) and 2 more.

DIN 05250129
Primary Designation Director
Industry Pharma
First Appointment 24 Apr 2012
Oldest Company Age 14 yrs
Largest company Fujin Kami Pharmaceutico Private Limited · ₹3.99 Cr (FY 2024)
Combined revenue ₹4.78 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 May 20192019₹3.99 Cr (FY 2024)Active
A-3 Overseas Private Limited U74999HR2016PTC063750
Director24 May 20232016₹79.2 Lakh (FY 2024)Active
Designated Partner26 Sep 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mutual Pharma Private Limited U51909HR2012PTC046908
Director27 Aug 20122012₹1.96 Cr (FY 2017)Active
Designated Partner07 Dec 20172017Converted To Cmp And Dissolved
Director07 Sep 20152015Strike Off
Director24 Apr 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Charanjeet Arora

Directorship timeline

Open interactive timeline →
Fujin Kami Pharmaceutico Llp
Uniblessed Pharma Llp
Fujin Kami Pharmaceutico Private Limited
Health Mitra Pharmacy Private Limited
Premium access

Shareholding and investment profile for Charanjeet Arora

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charanjeet Arora

Charanjeet Arora currently holds 3 directorships: Fujin Kami Pharmaceutico Private Limited (Director, since 23 May 2019, revenue ₹3.99 Cr (FY 2024)); A-3 Overseas Private Limited (Director, since 24 May 2023, revenue ₹79.2 Lakh (FY 2024)); Uniblessed Pharma Llp (Designated Partner, since 26 Sep 2017).

Charanjeet Arora was first appointed on 24 Apr 2012 as Director at Etek Retail Solutions India Private Limited. The most recent appointment on record is 24 May 2023 at A-3 Overseas Private Limited.

The 2 current companies of Charanjeet Arora that report revenue have a combined latest revenue of ₹4.78 Cr: Fujin Kami Pharmaceutico Private Limited ₹3.99 Cr (FY 2024); A-3 Overseas Private Limited ₹79.2 Lakh (FY 2024).

Charanjeet Arora held 4 earlier board appointments: Mutual Pharma Private Limited (Director, 27 Aug 2012 to 12 Sep 2013); Fujin Kami Pharmaceutico Llp (Designated Partner, from 07 Dec 2017); Health Mitra Pharmacy Private Limited (Director, from 07 Sep 2015); Etek Retail Solutions India Private Limited (Director, from 24 Apr 2012).

The current boards of Charanjeet Arora's companies include Vineet Rai (Fujin Kami Pharmaceutico Private Limited), Abheek Arora (A-3 Overseas Private Limited), Mahesh Kumar Arora (A-3 Overseas Private Limited), Surender Kumar Makkar (A-3 Overseas Private Limited), Rajesh (Uniblessed Pharma Llp), Rajesh Khatri (Uniblessed Pharma Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available